ISOTRETINOIN AND THE HUMAN MICROBIOME: EMERGING INSIGHTS INTO SKIN AND GUT INTERACTIONS
DOI:
https://doi.org/10.31435/ijitss.4(48).2025.4367Keywords:
Isotretinoin, Acne Vulgaris, Skin Microbiome, Gut Microbiota, Gut–Skin Axis, ProbioticsAbstract
Isotretinoin remains the most effective systemic therapy for severe acne vulgaris, yet growing evidence indicates that its therapeutic effects extend beyond sebaceous gland suppression and anti-inflammatory activity. Recent studies suggest that isotretinoin modulates both the skin and gut microbiota, influencing microbial diversity and host–microbe interactions. This narrative review summarizes current evidence published between 2017 and 2025 regarding isotretinoin’s impact on the skin and intestinal microbiota and its potential clinical implications. A structured literature search of PubMed, Scopus, Web of Science, and Google Scholar identified 28 relevant studies. The findings indicate that isotretinoin significantly reduces the abundance of Cutibacterium acnes while increasing overall microbial diversity, suggesting ecological restoration of the skin microbiome. Strain-level analyses reveal that isotretinoin selectively suppresses more virulent C. acnes phylogroups while promoting the persistence of commensal strains. Evidence from animal and clinical studies also points to mild, reversible changes in the gut microbiota, possibly mediated through systemic immune and metabolic pathways. Although concerns about isotretinoin-induced dysbiosis or inflammatory bowel disease remain largely unsupported, its systemic effects on microbial ecosystems warrant further investigation. Overall, isotretinoin should be regarded not only as a cornerstone acne therapy but also as a microbiome-modulating agent that may pave the way for more personalized and biologically informed dermatologic care.
References
McCoy, W. H. IV, Otchere, E., Rosa, B. A., Martin, J., Mann, C. M., & Mitreva, M. (2019). Skin ecology during sebaceous drought—How skin microbes respond to isotretinoin. The Journal of Investigative Dermatology, 139(3), 732–735. https://doi.org/10.1016/j.jid.2018.09.023
Nolan, Z. T., Banerjee, K., Cong, Z., Gettle, S. L., Longenecker, A. L., Kawasawa, Y. I., Zaenglein, A. L., Thiboutot, D. M., Agak, G. W., Zhan, X., & Nelson, A. M. (2023). Treatment response to isotretinoin correlates with specific shifts in Cutibacterium acnes strain composition within the follicular microbiome. Experimental Dermatology, 32(7), 955–964. https://doi.org/10.1111/exd.14798
Ryan-Kewley, A. E., Williams, D. R., Hepburn, N., & Dixon, R. A. (2017). Non-antibiotic isotretinoin treatment differentially controls Propionibacterium acnes on skin of acne patients. Frontiers in Microbiology, 8, 1381. https://doi.org/10.3389/fmicb.2017.01381
Liang, L., Qi, X., Jiang, X., Chen, T., & Dong, L. (2024). Lactobacillus plantarum MH-301 as an effective adjuvant to isotretinoin in the treatment of acne vulgaris: A randomized and open-label trial. Frontiers in Medicine, 10, 1340068. https://doi.org/10.3389/fmed.2023.1340068
Lam, M., Hu, A., Fleming, P., & Lynde, C. W. (2022). The impact of acne treatment on skin bacterial microbiota: A systematic review. Journal of Cutaneous Medicine and Surgery, 26(1), 93–97. https://doi.org/10.1177/12034754211037994
Dessinioti, C., & Katsambas, A. (2024). The microbiome and acne: Perspectives for treatment. Dermatology and Therapy, 14(1), 31–44. https://doi.org/10.1007/s13555-023-01079-8
Niedźwiedzka, A., Micallef, M. P., Biazzo, M., & Podrini, C. (2024). The role of the skin microbiome in acne: Challenges and future therapeutic opportunities. International Journal of Molecular Sciences, 25(21), 11422. https://doi.org/10.3390/ijms252111422
Huang, C., Zhuo, F., & Han, B. (2023). The updates and implications of cutaneous microbiota in acne. Cell Bioscience, 13, 113. https://doi.org/10.1186/s13578-023-01072-w
Deng, Y., Wang, H., Zhou, J., Mou, Y., Wang, G., & Xiong, X. (2018). Patients with acne vulgaris have a distinct gut microbiota in comparison with healthy controls. Acta Dermato-Venereologica, 98(8), 783–790. https://doi.org/10.2340/00015555-2968
Cao, Q., Guo, J., Chang, S., Huang, Z., & Luo, Q. (2023). Gut microbiota and acne: A Mendelian randomization study. Skin Research and Technology, 29(9), e13473. https://doi.org/10.1111/srt.13473
Cavallo, I., Sivori, F., Truglio, M., et al. (2022). Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents. Scientific Reports, 12, 21104. https://doi.org/10.1038/s41598-022-25436-3
Shi, J., Cheng, J., Zhang, Q., Hua, Z., & Miao, X. (2021). Comparison of the skin microbiota of patients with acne vulgaris and healthy controls. Annals of Palliative Medicine, 10(7), 7933–7941. https://doi.org/10.21037/apm-21-1482
Patangia, D. V. V., Ryan, C. A., Dempsey, E., Ross, R. P., & Stanton, C. (2022). Impact of antibiotics on the human microbiome and consequences for host health. MicrobiologyOpen, 11(1), e1260. https://doi.org/10.1002/mbo3.1260
Ghannoum, M. A., Long, L., Bunick, C. G., Del Rosso, J. Q., Gamal, A., Tyring, S. K., McCormick, T. S., & Grada, A. (2022). Sarecycline demonstrated reduced activity compared to minocycline against microbial species representing human gastrointestinal microbiota. Antibiotics, 11(3), 324. https://doi.org/10.3390/antibiotics11030324
Becker, E., Schmidt, T. S. B., Bengs, S., Poveda, L., Opitz, L., Atrott, K., Stanzel, C., Biedermann, L., Rehman, A., Jonas, D., von Mering, C., Rogler, G., & Frey-Wagner, I. (2017). Effects of oral antibiotics and isotretinoin on the murine gut microbiota. International Journal of Antimicrobial Agents, 50(3), 342–351. https://doi.org/10.1016/j.ijantimicag.2017.03.017
Ahmed, A., Liaquat, A., Raza, S., Koza, E., Ma, M., Haq, M., Shi, V., Rabeegh, A., Yi, M. D., Nadir, U., Cahn, B. A., Pearlman, R., Schlessinger, D. I., & Alam, M. (2024). Association of inflammatory bowel disease incidence with isotretinoin usage: A meta-analysis and systematic review. Journal of the American Academy of Dermatology, 91(5), 949–951. https://doi.org/10.1016/j.jaad.2024.06.068
Miqdad, M. A., Alatta, L., Abdelsamad, A., Fouda, S., Cherukuri, A. S. S., Eltanany, M., Albogami, F., Al Draiweesh, S., & Abdelrahman, N. (2022). Isotretinoin-induced inflammatory bowel disease: Is there a real association? Cureus, 14(10), e29825. https://doi.org/10.7759/cureus.29825
Chai, J., Deng, F., Li, Y., Wei, X., & Zhao, J. (2024). The gut-skin axis: Interaction of gut microbiome and skin diseases. Frontiers in Microbiology, 15, 1427770. https://doi.org/10.3389/fmicb.2024.1427770
Jiménez-Sánchez, M., Celiberto, L. S., Yang, H., Sham, H. P., & Vallance, B. A. (2025). The gut-skin axis: A bi-directional, microbiota-driven relationship with therapeutic potential. Gut Microbes, 17(1), 2473524. https://doi.org/10.1080/19490976.2025.2473524
Zhang, L., Cai, Y., Li, L., et al. (2025). Analysis of global trends and hotspots of skin microbiome in acne: A bibliometric perspective. BioData Mining, 18, 19. https://doi.org/10.1186/s13040-025-00433-0
Boyanova, L., Dimitrov, G., Raykova, V., Patrikov, K., Gergova, R., & Markovska, R. (2025). Cutibacterium acnes phylotyping and antibiotic resistance to six antibiotics: A Bulgarian study. Microorganisms, 13(9), 2185. https://doi.org/10.3390/microorganisms13092185
Feidenhansl, C., Lund, M., Poehlein, A., Lood, R., Lomholt, H. B., & Brüggemann, H. (2024). Cutibacterium and Staphylococcus dysbiosis of the skin microbiome in acne and its decline after isotretinoin treatment. Journal of Cosmetic Dermatology, 23(6), e487. https://doi.org/10.1002/jvc2.487
Podwojniak, A., Niedźwiedzka, A., Biazzo, M., & Podrini, C. (2025). Acne and the cutaneous microbiome: A systematic review. Journal of the European Academy of Dermatology and Venereology, 39(2), 223–238. https://doi.org/10.1111/jdv.19752
Bonakdar, M., Czuba, L. C., Han, G., Zhong, G., Luong, H., Isoherranen, N., & Vaishnava, S. (2022). Gut commensals expand vitamin A metabolic capacity of the mammalian host. Cell Host & Microbe, 30(8), 1084–1092.e5. https://doi.org/10.1016/j.chom.2022.06.011
Dessinioti, C., & Katsambas, A. (2024). The microbiome and acne: Perspectives for treatment. Dermatology and Therapy, 14(1), 31–44. https://doi.org/10.1007/s13555-023-01079-8
Lam, M., Hu, A., Fleming, P., & Lynde, C. W. (2022). The impact of acne treatment on skin bacterial microbiota: A systematic review. Journal of Cutaneous Medicine and Surgery, 26(1), 93–97. https://doi.org/10.1177/12034754211037994
Zhu, C., Wei, B., Li, Y., & Wang, C. (2025). Antibiotic resistance rates in Cutibacterium acnes isolated from patients with acne vulgaris: A systematic review and meta-analysis. Frontiers in Microbiology, 16, 1565111. https://doi.org/10.3389/fmicb.2025.1565111
Huang, Y., Liu, F., Lai, J., Jiang, S., Tan, X., Chen, L., & Deng, Y. (2024). The adjuvant treatment role of ω-3 fatty acids by regulating gut microbiota positively in acne vulgaris. Journal of Dermatological Treatment, 35(1), 1–9. https://doi.org/10.1080/09546634.2023.2299107
Downloads
Published
Issue
Section
License
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
